Ashland Global Holdings Inc (ASH) - Net Assets
Based on the latest financial reports, Ashland Global Holdings Inc (ASH) has net assets worth $1.88 Billion USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($4.52 Billion) and total liabilities ($2.64 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are Ashland Global Holdings Inc's assets to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.88 Billion |
| % of Total Assets | 41.56% |
| Annual Growth Rate | 1.81% |
| 5-Year Change | -30.81% |
| 10-Year Change | -39.84% |
| Growth Volatility | 14.32 |
Ashland Global Holdings Inc - Net Assets Trend (1985–2025)
This chart illustrates how Ashland Global Holdings Inc's net assets have evolved over time, based on quarterly financial data. Also explore Ashland Global Holdings Inc balance sheet assets for the complete picture of this company's asset base.
Annual Net Assets for Ashland Global Holdings Inc (1985–2025)
The table below shows the annual net assets of Ashland Global Holdings Inc from 1985 to 2025. For live valuation and market cap data, see Ashland Global Holdings Inc (ASH) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $1.90 Billion | -33.61% |
| 2024-09-30 | $2.87 Billion | -7.39% |
| 2023-09-30 | $3.10 Billion | -3.82% |
| 2022-09-30 | $3.22 Billion | +17.01% |
| 2021-09-30 | $2.75 Billion | -9.35% |
| 2020-09-30 | $3.04 Billion | -14.98% |
| 2019-09-30 | $3.57 Billion | +4.84% |
| 2018-09-30 | $3.41 Billion | 0.00% |
| 2017-09-30 | $3.41 Billion | +7.61% |
| 2016-09-30 | $3.17 Billion | +4.21% |
| 2015-09-30 | $3.04 Billion | -15.24% |
| 2014-09-30 | $3.58 Billion | -21.30% |
| 2013-09-30 | $4.55 Billion | +13.01% |
| 2012-09-30 | $4.03 Billion | -2.56% |
| 2011-09-30 | $4.13 Billion | +8.73% |
| 2010-09-30 | $3.80 Billion | +6.11% |
| 2009-09-30 | $3.58 Billion | +11.93% |
| 2008-09-30 | $3.20 Billion | +1.52% |
| 2007-09-30 | $3.15 Billion | +1.87% |
| 2006-09-30 | $3.10 Billion | -17.20% |
| 2005-09-30 | $3.74 Billion | +38.17% |
| 2004-09-30 | $2.71 Billion | +20.11% |
| 2003-09-30 | $2.25 Billion | +3.68% |
| 2002-09-30 | $2.17 Billion | -2.38% |
| 2001-09-30 | $2.23 Billion | +13.28% |
| 2000-09-30 | $1.97 Billion | -10.68% |
| 1999-09-30 | $2.20 Billion | +2.95% |
| 1998-09-30 | $2.14 Billion | -6.97% |
| 1997-09-30 | $2.30 Billion | +15.54% |
| 1996-09-30 | $1.99 Billion | +20.12% |
| 1995-09-30 | $1.66 Billion | +3.76% |
| 1994-09-30 | $1.59 Billion | +9.64% |
| 1993-09-30 | $1.45 Billion | +33.96% |
| 1992-09-30 | $1.09 Billion | -24.77% |
| 1991-09-30 | $1.44 Billion | +12.77% |
| 1990-09-30 | $1.28 Billion | +12.23% |
| 1989-09-30 | $1.14 Billion | +1.74% |
| 1988-09-30 | $1.12 Billion | +5.22% |
| 1987-09-30 | $1.07 Billion | +9.72% |
| 1986-09-30 | $971.00 Million | +4.48% |
| 1985-09-30 | $929.40 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Ashland Global Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 232.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $2.30 Billion | 120.69% |
| Common Stock | $1.00 Million | 0.05% |
| Other Comprehensive Income | $-401.00 Million | -21.06% |
| Other Components | $6.00 Million | 0.32% |
| Total Equity | $1.90 Billion | 100.00% |
Ashland Global Holdings Inc Competitors by Market Cap
The table below lists competitors of Ashland Global Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Jinyu Bio-Technology Co Ltd
SHG:600201
|
$2.37 Billion |
|
TIZA Information Industry Corporation Inc
SHE:300209
|
$2.37 Billion |
|
Distribuidora Internacional de Alimentación S.A
MC:DIA
|
$2.37 Billion |
|
Bingo Software Co Ltd
SHG:688227
|
$2.37 Billion |
|
Multipolar Technology Tbk
JK:MLPT
|
$2.37 Billion |
|
SBT Ultrasonic Technology Co. Ltd. A
SHG:688392
|
$2.37 Billion |
|
Alsea S.A.B. de C.V
MX:ALSEA
|
$2.37 Billion |
|
Jonjee Hi-tech Industrial and Commercial Holding Co Ltd
SHG:600872
|
$2.37 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ashland Global Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,868,000,000 to 1,904,000,000, a change of -964,000,000 (-33.6%).
- Net loss of 845,000,000 reduced equity.
- Dividend payments of 76,000,000 reduced retained earnings.
- Share repurchases of 100,000,000 reduced equity.
- Other comprehensive income increased equity by 47,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-845.00 Million | -44.38% |
| Dividends Paid | $76.00 Million | -3.99% |
| Share Repurchases | $100.00 Million | -5.25% |
| Other Comprehensive Income | $47.00 Million | +2.47% |
| Other Changes | $10.00 Million | +0.53% |
| Total Change | $- | -33.61% |
Book Value vs Market Value Analysis
This analysis compares Ashland Global Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.25x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.17x to 1.25x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1985-09-30 | $16.37 | $51.82 | x |
| 1986-09-30 | $14.92 | $51.82 | x |
| 1987-09-30 | $17.17 | $51.82 | x |
| 1988-09-30 | $20.07 | $51.82 | x |
| 1989-09-30 | $20.51 | $51.82 | x |
| 1990-09-30 | $22.49 | $51.82 | x |
| 1991-09-30 | $25.29 | $51.82 | x |
| 1992-09-30 | $18.60 | $51.82 | x |
| 1993-09-30 | $22.51 | $51.82 | x |
| 1994-09-30 | $22.15 | $51.82 | x |
| 1995-09-30 | $26.48 | $51.82 | x |
| 1996-09-30 | $27.97 | $51.82 | x |
| 1997-09-30 | $27.39 | $51.82 | x |
| 1998-09-30 | $27.69 | $51.82 | x |
| 1999-09-30 | $29.33 | $51.82 | x |
| 2000-09-30 | $27.51 | $51.82 | x |
| 2001-09-30 | $31.66 | $51.82 | x |
| 2002-09-30 | $31.02 | $51.82 | x |
| 2003-09-30 | $33.04 | $51.82 | x |
| 2004-09-30 | $38.01 | $51.82 | x |
| 2005-09-30 | $50.10 | $51.82 | x |
| 2006-09-30 | $43.00 | $51.82 | x |
| 2007-09-30 | $49.37 | $51.82 | x |
| 2008-09-30 | $50.43 | $51.82 | x |
| 2009-09-30 | $49.10 | $51.82 | x |
| 2010-09-30 | $48.14 | $51.82 | x |
| 2011-09-30 | $51.69 | $51.82 | x |
| 2012-09-30 | $50.36 | $51.82 | x |
| 2013-09-30 | $56.91 | $51.82 | x |
| 2014-09-30 | $45.94 | $51.82 | x |
| 2015-09-30 | $44.01 | $51.82 | x |
| 2016-09-30 | $53.13 | $51.82 | x |
| 2017-09-30 | $54.94 | $51.82 | x |
| 2018-09-30 | $53.22 | $51.82 | x |
| 2019-09-30 | $56.68 | $51.82 | x |
| 2020-09-30 | $49.77 | $51.82 | x |
| 2021-09-30 | $45.11 | $51.82 | x |
| 2022-09-30 | $57.50 | $51.82 | x |
| 2023-09-30 | $57.35 | $51.82 | x |
| 2024-09-30 | $57.36 | $51.82 | x |
| 2025-09-30 | $41.39 | $51.82 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ashland Global Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -44.38%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -46.33%
- • Asset Turnover: 0.40x
- • Equity Multiplier: 2.42x
- Recent ROE (-44.38%) is below the historical average (7.68%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1985 | 15.78% | 1.86% | 2.01x | 4.23x | $53.76 Million |
| 1986 | 21.48% | 2.98% | 1.84x | 3.92x | $111.50 Million |
| 1987 | 12.52% | 1.94% | 1.69x | 3.81x | $26.86 Million |
| 1988 | 16.40% | 2.35% | 1.84x | 3.80x | $71.70 Million |
| 1989 | 7.56% | 1.07% | 1.81x | 3.91x | $-27.85 Million |
| 1990 | 14.23% | 2.14% | 1.66x | 4.00x | $54.10 Million |
| 1991 | 10.05% | 1.57% | 1.70x | 3.77x | $650.00K |
| 1992 | -30.91% | -3.51% | 1.69x | 5.22x | $-444.30 Million |
| 1993 | 9.77% | 1.49% | 1.72x | 3.82x | $-3.28 Million |
| 1994 | 12.35% | 2.08% | 1.63x | 3.65x | $37.50 Million |
| 1995 | 1.45% | 0.21% | 1.60x | 4.22x | $-141.50 Million |
| 1996 | 11.63% | 1.86% | 1.56x | 4.01x | $29.60 Million |
| 1997 | 13.78% | 2.17% | 1.65x | 3.84x | $76.60 Million |
| 1998 | 9.50% | 3.11% | 1.07x | 2.85x | $-10.70 Million |
| 1999 | 13.18% | 4.26% | 1.06x | 2.92x | $70.00 Million |
| 2000 | 3.56% | 0.88% | 1.18x | 3.45x | $-126.50 Million |
| 2001 | 18.73% | 4.88% | 1.23x | 3.12x | $194.40 Million |
| 2002 | 5.38% | 1.54% | 1.13x | 3.09x | $-100.30 Million |
| 2003 | 3.33% | 0.95% | 1.13x | 3.11x | $-150.30 Million |
| 2004 | 13.97% | 6.08% | 0.83x | 2.77x | $107.40 Million |
| 2005 | 53.60% | 27.47% | 1.07x | 1.82x | $1.63 Billion |
| 2006 | 13.15% | 5.63% | 1.10x | 2.13x | $97.40 Million |
| 2007 | 7.29% | 2.95% | 1.37x | 1.80x | $-85.40 Million |
| 2008 | 5.22% | 1.99% | 1.45x | 1.80x | $-153.20 Million |
| 2009 | 1.98% | 0.88% | 0.86x | 2.64x | $-287.40 Million |
| 2010 | 3.71% | 2.46% | 0.60x | 2.51x | $-239.30 Million |
| 2011 | 10.01% | 6.37% | 0.50x | 3.14x | $500.00K |
| 2012 | 0.65% | 0.40% | 0.52x | 3.11x | $-376.90 Million |
| 2013 | 15.00% | 11.21% | 0.50x | 2.65x | $227.70 Million |
| 2014 | 6.50% | 3.81% | 0.56x | 3.06x | $-125.30 Million |
| 2015 | 10.17% | 9.04% | 0.34x | 3.31x | $5.30 Million |
| 2016 | -0.87% | -0.96% | 0.30x | 2.99x | $-363.70 Million |
| 2017 | 0.03% | 0.04% | 0.27x | 2.53x | $-339.60 Million |
| 2018 | 3.35% | 4.40% | 0.31x | 2.42x | $-226.60 Million |
| 2019 | 14.14% | 23.51% | 0.30x | 2.03x | $147.90 Million |
| 2020 | -16.73% | -25.20% | 0.29x | 2.27x | $-811.60 Million |
| 2021 | 7.99% | 10.42% | 0.32x | 2.40x | $-55.20 Million |
| 2022 | 28.79% | 38.77% | 0.38x | 1.93x | $605.00 Million |
| 2023 | 5.75% | 8.12% | 0.37x | 1.92x | $-131.70 Million |
| 2024 | 5.89% | 8.00% | 0.37x | 1.97x | $-117.80 Million |
| 2025 | -44.38% | -46.33% | 0.40x | 2.42x | $-1.04 Billion |
Industry Comparison
This section compares Ashland Global Holdings Inc's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $706,878,196
- Average return on equity (ROE) among peers: 4.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ashland Global Holdings Inc (ASH) | $1.88 Billion | 15.78% | 1.41x | $2.37 Billion |
| Albemarle Corp (ALB) | $1.03 Billion | 13.91% | 1.46x | $19.80 Billion |
| Alto Ingredients Inc (ALTO) | $383.70 Million | -9.11% | 0.88x | $212.84 Million |
| Aemetis Inc (AMTX) | $-35.29 Million | 0.00% | 0.00x | $154.69 Million |
| Air Products and Chemicals Inc (APD) | $3.09 Billion | 14.58% | 1.67x | $62.29 Billion |
| Avient Corp (AVNT) | $649.70 Million | 1.75% | 1.44x | $3.16 Billion |
| Axalta Coating Systems Ltd (AXTA) | $1.21 Billion | -18.56% | 4.56x | $5.92 Billion |
| Balchem Corporation (BCPC) | $1.80 Million | 22.22% | 1.00x | $5.17 Billion |
| BioNexus Gene Lab Corp Common stock (BGLC) | $6.67 Million | -5.34% | 0.31x | $4.91 Million |
| Bon Natural Life Ltd (BON) | $26.53 Million | 17.30% | 0.37x | $7.91 Million |
About Ashland Global Holdings Inc
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet … Read more